In a similar vein, 4-1BB/VEGF aptamer conjugates were able to enhance T cell proliferation when administered systemically to mice bearing subcutaneous 4T1 mammary carcinomas or MCA induced fibrosarcoma in a VEGF-dependent manner (128). This evidence concerns the gene VEGFA and breast carcinoma.